UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma

Journal of neuro-oncology, 2018, Vol.136 (1), p.115-125

2018

Volltextzugriff (PDF)

Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma

Journal of neuro-oncology, 2016-05, Vol.128 (1), p.147-155

2016

Volltextzugriff (PDF)

P16.09 VALUE OF FET-PET EVALUATION IN PATIENTS TREATED WITH AXITINIB

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii79-ii80

2014

Volltextzugriff (PDF)

O1.05 AXITINIB, A SELECTIVE VEGFR-1,-2,-3 TYROSINE KINASE INHIBITOR, INHIBITS TUMOR GROWTH AND INCREASES INFILTRATION OF IMMUNE CELLS IN AN INTRACRANIAL MELANOMA MOUSE MODEL

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii2-ii2

2014

Volltextzugriff (PDF)

O10.07 RANDOMIZED PHASE II STUDY OF AXITINIB VS. STANDARD OF CARE IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (suppl 2), p.ii24-ii25

2014

Volltextzugriff (PDF)

Deep brain stimulation in Bassen-Kornzweig syndrome: Still effective after 22 years

Brain & spine, 2023, Vol.3, p.101762, Article 101762

2023

Volltextzugriff (PDF)

Erections Upon Walking. A Less Known Symptom of Lumbar Canal Stenosis

World neurosurgery, 2013-11, Vol.80 (5), p.666-666

2013

Volltextzugriff (PDF)

Prognostic value of 0-(2-[18F]-fluoroethyl)-L-tyrosine PET in patients with recurrent GBM

Brain & spine, 2022, Vol.2, p.101503, Article 101503

2022

Volltextzugriff (PDF)

Properties of amorphous and crystalline Ta2O5 thin films deposited on Si from a Ta(OC2H5)5 precursor

Journal of applied physics, 1998-05, Vol.83 (9), p.4823-4829

1998

Volltextzugriff (PDF)

Single-center experience with ipilimumab in an expanded access program for patients with pretreated advanced melanoma

Journal of immunotherapy (1997), 2013-04, Vol.36 (3), p.215-222

2013

Volltextzugriff (PDF)

Comparison between the properties of amorphous and crystalline Ta2O5 thin films deposited on Si

Microelectronics and reliability, 1999-02, Vol.39 (2), p.261-268

1999

Volltextzugriff (PDF)

Sarcoidosis in a Patient with Metastatic Melanoma Sequentially Treated with Anti-CTLA-4 Monoclonal Antibody and Selective BRAF Inhibitor

Anticancer research, 2012-04, Vol.32 (4), p.1355-1359

2012

Volltextzugriff (PDF)

Kinetics and characterization of plasma grown aluminium oxide

Journal of applied physics, 1998-05, Vol.83 (10), p.5570-5572

1998

Volltextzugriff (PDF)

Characterization of plasma deposited Ta2O5 films using grazing incidence x-ray scattering

Journal of vacuum science & technology. A, Vacuum, surfaces, and films, 2000-03, Vol.18 (2), p.554-556

2000

Volltextzugriff (PDF)

P08.09 Axitinib for the treatment of patients with recurrent glioblastoma, final results from a randomized phase II clinical trial

Neuro-oncology (Charlottesville, Va.), 2016-10, Vol.18 (suppl_4), p.iv41-iv42

2016

Volltextzugriff (PDF)

O1.05AXITINIB, A SELECTIVE VEGFR-1,-2,-3 TYROSINE KINASE INHIBITOR, INHIBITS TUMOR GROWTH AND INCREASES INFILTRATION OF IMMUNE CELLS IN AN INTRACRANIAL MELANOMA MOUSE MODEL

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (Suppl 2), p.ii2-ii2

2014

Volltextzugriff (PDF)

P16.09VALUE OF FET-PET EVALUATION IN PATIENTS TREATED WITH AXITINIB

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (Suppl 2), p.ii79-ii80

2014

Volltextzugriff (PDF)

O10.07RANDOMIZED PHASE II STUDY OF AXITINIB VS. STANDARD OF CARE IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2014-09, Vol.16 (Suppl 2), p.ii24-ii25

2014

Volltextzugriff (PDF)

Theoretical and experimental study of the conduction mechanism in Al/Ta2O5/SiO2/Si and Al/Ta2O5/Si3N4/Si structures

Journal of non-crystalline solids, 1999-04, Vol.245 (1-3), p.73-78

1999

Volltextzugriff (PDF)

Effects of deposition conditions on the fluorine and hydrogen concentration in tantalum pentoxide ( Ta 2 O 5 ) thin films prepared by plasma enhanced chemical vapor deposition using a tantalum pentafluoride (TaF 5 ) source

Journal of vacuum science & technology. A, Vacuum, surfaces, and films, 1999-11, Vol.17 (6), p.3235-3239

1999

Volltextzugriff (PDF)

Properties of tantalum pentoxide (Ta2O5) obtained by plasma assisted deposition using a TaF5 source

Journal of non-crystalline solids, 1999-09, Vol.254 (1-3), p.139-145

1999

Volltextzugriff (PDF)

CeCil: A randomized, noncomparative phase II clinical trial of the effect of radiation therapy (RT) plus temozolomide (TMZ) combined with cilengitide or cetuximab on the 1-year overall survival of patients with newly diagnosed MGMT-promoter unmethylated glioblastoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS134-TPS134

2011

Volltextzugriff (PDF)

Characterization of plasma deposited Ta sub(2)O sub(5) films using grazing incidence x-ray scattering

Journal of vacuum science & technology. A, Vacuum, surfaces, and films, 2000-03, Vol.18 (2), p.554-556

2000

Volltextzugriff (PDF)

Deep brain stimulation in Bassen-Kornzweig syndrome: Still effective after 22 years

Brain & spine, 2023, Vol.3, p.101762-101762

2023

Volltextzugriff (PDF)

Characterization of plasma deposited Ta 2 O 5 films using grazing incidence x-ray scattering

Journal of vacuum science & technology. A, Vacuum, surfaces, and films, 2000-03, Vol.18 (2), p.554-556

2000

Volltextzugriff (PDF)

1 – 25 von 587

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(384)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma

Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma

P16.09 VALUE OF FET-PET EVALUATION IN PATIENTS TREATED WITH AXITINIB

O1.05 AXITINIB, A SELECTIVE VEGFR-1,-2,-3 TYROSINE KINASE INHIBITOR, INHIBITS TUMOR GROWTH AND INCREASES INFILTRATION OF IMMUNE CELLS IN AN INTRACRANIAL MELANOMA MOUSE MODEL

O10.07 RANDOMIZED PHASE II STUDY OF AXITINIB VS. STANDARD OF CARE IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Deep brain stimulation in Bassen-Kornzweig syndrome: Still effective after 22 years

Erections Upon Walking. A Less Known Symptom of Lumbar Canal Stenosis

Prognostic value of 0-(2-[18F]-fluoroethyl)-L-tyrosine PET in patients with recurrent GBM

Properties of amorphous and crystalline Ta2O5 thin films deposited on Si from a Ta(OC2H5)5 precursor

Single-center experience with ipilimumab in an expanded access program for patients with pretreated advanced melanoma

Comparison between the properties of amorphous and crystalline Ta2O5 thin films deposited on Si

Sarcoidosis in a Patient with Metastatic Melanoma Sequentially Treated with Anti-CTLA-4 Monoclonal Antibody and Selective BRAF Inhibitor

Kinetics and characterization of plasma grown aluminium oxide

Characterization of plasma deposited Ta2O5 films using grazing incidence x-ray scattering

P08.09 Axitinib for the treatment of patients with recurrent glioblastoma, final results from a randomized phase II clinical trial

O1.05AXITINIB, A SELECTIVE VEGFR-1,-2,-3 TYROSINE KINASE INHIBITOR, INHIBITS TUMOR GROWTH AND INCREASES INFILTRATION OF IMMUNE CELLS IN AN INTRACRANIAL MELANOMA MOUSE MODEL

P16.09VALUE OF FET-PET EVALUATION IN PATIENTS TREATED WITH AXITINIB

O10.07RANDOMIZED PHASE II STUDY OF AXITINIB VS. STANDARD OF CARE IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Theoretical and experimental study of the conduction mechanism in Al/Ta2O5/SiO2/Si and Al/Ta2O5/Si3N4/Si structures

Effects of deposition conditions on the fluorine and hydrogen concentration in tantalum pentoxide ( Ta 2 O 5 ) thin films prepared by plasma enhanced chemical vapor deposition using a tantalum pentafluoride (TaF 5 ) source

Properties of tantalum pentoxide (Ta2O5) obtained by plasma assisted deposition using a TaF5 source

CeCil: A randomized, noncomparative phase II clinical trial of the effect of radiation therapy (RT) plus temozolomide (TMZ) combined with cilengitide or cetuximab on the 1-year overall survival of patients with newly diagnosed MGMT-promoter unmethylated glioblastoma

Characterization of plasma deposited Ta sub(2)O sub(5) films using grazing incidence x-ray scattering

Deep brain stimulation in Bassen-Kornzweig syndrome: Still effective after 22 years

Characterization of plasma deposited Ta 2 O 5 films using grazing incidence x-ray scattering

Suchergebnisse filtern